血管内取栓后恶性特征急性缺血性卒中的目标温度管理临床效用
本研究基于多中心血管内治疗登记,纳入前循环卒中行血管内再通患者,恶性特征定义为基线ASPECTS低于6且DWI病灶体积大于82 ml或NIHSS评分大于20且Ia项大于0。目标温度管理(TTM)组(n=91)维持34.5°C至少48小时,其基线ASPECTS更低、DWI体积更大;总体TTM组3个月改良Rankin量表0-2分比例低于非TTM组(p=0.008)。在恶性特征亚组(n=80)中,TTM组(n=28)良好预后比例高于非TTM组(n=52)(32.1% vs. 7.7%,p=0.009),且出血转化更少(无出血 vs. 任何出血,p=0.007)。校正潜在预后预测因素后,TTM(OR 4.63;CI 1.20-17.89;p=0.026)和高血压(OR 0.18;CI 0.04-0.74;p=0.018)为独立决定因素。作者结论认为TTM可能减轻即将发生的出血转化并带来良好临床结局。
要点
- 恶性特征定义为基线ASPECTS低于6且DWI病灶体积大于82 ml或NIHSS评分大于20且Ia项大于0。
- 恶性特征亚组中,TTM组3个月mRS 0-2分比例为32.1%,非TTM组为7.7%(p=0.009)。
- 恶性特征亚组中,TTM组无出血转化,非TTM组有任何出血转化(p=0.007)。
- 总体队列中TTM组良好预后比例低于非TTM组(p=0.008),但TTM组基线ASPECTS更低、DWI体积更大。
- 校正潜在预后预测因素后,TTM(OR 4.63;CI 1.20-17.89;p=0.026)和高血压(OR 0.18;CI 0.04-0.74;p=0.018)为独立决定因素。
适用人群与场景
- 前循环卒中接受血管内再通治疗的患者。
- 恶性特征定义为(1)基线ASPECTS低于6和(2)DWI病灶体积大于82 ml或NIHSS评分大于20且Ia项大于0。
- 恶性特征亚组分析纳入80例患者,其中TTM组28例,非TTM组52例。
诊断标准与关键阈值
- 恶性特征:基线ASPECTS低于6,且DWI病灶体积大于82 ml或NIHSS评分大于20且Ia项大于0。
- 良好预后:3个月改良Rankin量表评分0-2分。
处置流程与药物剂量
- TTM组维持目标温度34.5°C至少48小时。
研究设计与关键结果
- 多中心血管内治疗登记研究,共纳入548例前循环卒中行血管内再通患者,TTM组91例,非TTM组457例。
- TTM组基线ASPECTS显著低于非TTM组(p<0.001),DWI体积显著高于非TTM组(p<0.001)。
- 总体队列中TTM组3个月mRS 0-2分比例低于非TTM组(p=0.008)。
- 恶性特征亚组(n=80)中,TTM组(n=28)良好预后比例32.1%,非TTM组(n=52)为7.7%(p=0.009)。
- 恶性特征亚组中,TTM组无出血转化,非TTM组有任何出血转化(p=0.007)。
- 校正潜在预后预测因素后,TTM(OR 4.63;CI 1.20-17.89;p=0.026)和高血压(OR 0.18;CI 0.04-0.74;p=0.018)为独立决定因素。
证据类型、等级与局限
- 证据类型:多中心血管内治疗登记研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,TTM可能减轻即将发生的出血转化并在血管内取栓后具恶性特征的患者中带来良好临床结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND/OBJECTIVE: Targeted temperature management (TTM) may be more beneficial after endovascular treatment (EVT) in patients with a large ischemic core. Therefore, we assessed the usefulness of TTM for such patients from a multicenter endovascular registry.
METHODS: Anterior circulation stroke patients who underwent endovascular recanalization were included; acute ischemic stroke with malignant traits was designated as (1) baseline Alberta Stroke Program Early CT Score (ASPECTS) below 6 and (2) diffusion-weighted imaging (DWI) lesion volume measurement (> 82 ml) or National Institutes of Health Stroke Scale score > 20 and item Ia > 0. TTM (34.5 °C) was maintained for at least 48 h.
RESULTS: We evaluated baseline demographics, risk factors, EVT parameters, and clinical outcomes between the TTM and non-TTM groups. Among the 548 patients, the TTM group (n = 91) significantly had a lower baseline ASPECTS (p < 0.001) and a higher DWI volume (p < 0.001) than the non-TTM group (n = 457). TTM group had a lower prevalence of favorable outcome (0-2 of modified Rankin Scale at 3 months; p = 0.008) than the non-TTM group. In a subgroup analysis of malignant trait patients (n = 80), TTM patients (n = 28) had more favorable outcome (32.1% vs. 7.7% p = 0.009) and less hemorrhagic transformation (none vs. any hemorrhage, p = 0.007) than non-TTM patients (n = 52). After adjusting for potential outcome predictors, TTM (odds ratio [OR] 4.63; confidence interval [CI] 1.20-17.89; p = 0.026) and hypertension (OR 0.18; CI 0.04-0.74; p = 0.018) were found to be independent determinants.
CONCLUSIONS: Our data suggest that TTM attenuates impending hemorrhagic transformation and leads to favorable clinical outcomes in EVT patients with malignant trait.
参考来源
- Choi MH, Gil YE, Lee SJ, et al. The Clinical Usefulness of Targeted Temperature Management in Acute Ischemic Stroke with Malignant Trait After Endovascular Thrombectomy. Neurocrit Care. 2020. PMID: 32812197. doi:10.1007/s12028-020-01069-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。